3151.T Stock - Vital KSK Holdings, Inc.
Unlock GoAI Insights for 3151.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $600.37B | $587.48B | $579.77B | $577.25B | $537.06B |
| Gross Profit | $49.22B | $48.30B | $44.96B | $43.98B | $38.22B |
| Gross Margin | 8.2% | 8.2% | 7.8% | 7.6% | 7.1% |
| Operating Income | $5.71B | $5.56B | $4.02B | $2.94B | $-2,260,000,000 |
| Net Income | $7.31B | $5.84B | $4.83B | $4.77B | $1.17B |
| Net Margin | 1.2% | 1.0% | 0.8% | 0.8% | 0.2% |
| EPS | $149.01 | $115.02 | $92.69 | $87.88 | $21.25 |
Vital KSK Holdings, Inc. engages in the wholesale of pharmaceutical products in Japan. The company is involved in the wholesale of veterinary drugs; agricultural chemicals, agricultural materials, etc.; and medical and nursing care equipment. It also engages in the pharmacy and nursing care businesses; transportation business; insurance agent and real estate management businesses; parking business; mail-order business of health-related products; and pharmacy dispensing business. In addition, the company offers medical management consulting services; and manufactures OTC drugs. The company was founded in 2009 and is headquartered in Tokyo, Japan.
Visit WebsiteEarnings History & Surprises
3151.TEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | $88.50 | — | — |
Q3 2025 | Aug 6, 2025 | — | $14.36 | — | — |
Q2 2025 | May 14, 2025 | — | $17.58 | — | — |
Q1 2025 | Feb 12, 2025 | — | $83.17 | — | — |
Q4 2024 | Nov 1, 2024 | — | $27.90 | — | — |
Q3 2024 | Aug 6, 2024 | — | $20.88 | — | — |
Q2 2024 | May 13, 2024 | — | $15.72 | — | — |
Q1 2024 | Feb 7, 2024 | — | $53.65 | — | — |
Q4 2023 | Nov 6, 2023 | — | $28.04 | — | — |
Q3 2023 | Aug 2, 2023 | — | $17.79 | — | — |
Q2 2023 | May 12, 2023 | — | $46.30 | — | — |
Q1 2023 | Feb 3, 2023 | — | $19.23 | — | — |
Q4 2022 | Nov 10, 2022 | — | $15.39 | — | — |
Q3 2022 | Aug 2, 2022 | — | $12.05 | — | — |
Q2 2022 | May 12, 2022 | — | $43.56 | — | — |
Q1 2022 | Feb 3, 2022 | — | $19.25 | — | — |
Q4 2021 | Nov 9, 2021 | — | $14.02 | — | — |
Q3 2021 | Aug 3, 2021 | — | $11.66 | — | — |
Q2 2021 | May 13, 2021 | — | $15.14 | — | — |
Q1 2021 | Feb 3, 2021 | — | $-1.86 | — | — |
Latest News
Frequently Asked Questions about 3151.T
What is 3151.T's current stock price?
What is the analyst price target for 3151.T?
What sector is Vital KSK Holdings, Inc. in?
What is 3151.T's market cap?
Does 3151.T pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to 3151.T for comparison